In the Last 7 days there's been 30 influencers like pharminews and JohnCendpts, discussing topics such as #news, #pharmaand #pharmiweb.



Trends


Top hashtags

Top influencers

  pharminews
  JohnCendpts
  biospace
  SynBioBeta
  GENbio
  BioWorld
  NatureBiotech
  MassBio
  Roche

Top sources

source img pharmiweb.com
source img biospace.com
source img endpts.com
source img bioworld.com
source img genengnews.com
source img fiercebiotech.com
source img nytimes.com
source img news.bms.com
source img labiotech.eu

News

The top 10 takeover targets in biopharma

On Oct 19, 2020
@FierceBiotech shared
M&A activity still looks fairly lively in 2020 despite a somewhat subdued start as the industry adapted to the looming coronavirus pandemic. https://t.co/u7ZpDjIr71
Open

Most if not all large-cap pharma and biotech companies are still in need of business development as they work to rebalance their operations. Cancer, rare disease, and to a lesser extent central nervous system players are targets that match up most closely with prospective buyers.

www.fiercebiotech.com
On Oct 19, 2020
@FierceBiotech shared
M&A activity still looks fairly lively in 2020 despite a somewhat subdued start as the industry adapted to the looming coronavirus pandemic. https://t.co/u7ZpDjIr71
Open

The top 10 takeover targets in biopharma

The top 10 takeover targets in biopharma

Most if not all large-cap pharma and biotech companies are still in need of business development as they work to rebalance their operations. Cancer, rare disease, and to a lesser extent ...


On Oct 13, 2020
@Biotechnology shared
Exploding Biopharma Industry Going the Distance for Specialized Talent https://t.co/DMuPa6CD7k https://t.co/9UcgzoN9fO
Open

Exploding Biopharma Industry Going the Distance for Specialized Talent

Exploding Biopharma Industry Going the Distance for Specialized Talent

The urgency of 2020 has shone a spotlight on the investment and advances in the U.S. biotech industry over the past decade – and overall, it is looking strong.

On Oct 15, 2020
@biospace shared
Biopharma Money on the Move: October 7-14 #biospace #lifesciences #biotechnology #pharmaceuticals #biopharma https://t.co/9x2rex1r6l
Open

Biopharma Money on the Move: October 7-14

Biopharma Money on the Move: October 7-14

Find out which life sciences companies are raking in the cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.

On Oct 14, 2020
@Labiotech_eu shared
#Patent law is a thorny area, and #biotechnology is no exception. Carly Klein lays out the complexity of the issue using two major cases that've defined the intellectual property side of biotech: those of the firm #Myriad and the gene editing tool #CRISPR. https://t.co/nlxjMZY9SR
Open

The Complications Around Patenting Biotechnology

The Complications Around Patenting Biotechnology

Many people around the world start their mornings with a glass of orange juice. What these vitamin C drinkers might not know is that their ability to enjoy this tangy beverage stems from a ...

On Oct 16, 2020
@GENbio shared
[email protected] raises $30 M in Financing. The new funding will help take their manufacturing platform to the market that delivers solutions to address the clinical and commercial manufacturing needs of cell and #genetherapy developers. Learn more: https://t.co/3KDStJHa7A https://t.co/FryA7W3zq3
Open

Ori Biotech Raises $30 Million in Financing

Ori Biotech Raises $30 Million in Financing

 Funds will be used to advance innovation in cell and gene therapy manufacturing.

On Oct 18, 2020
@NatureBiotech shared
RT @UMassMedical: Guangping Gao, PhD, & #NobelPrize2020 winner Jennifer Doudna are both on @NatureBiotech's list of top translational biotech researchers for 2019. The #genetherapy pioneer & director of @UMMSGeneTherapy was on the 2018 list too. https://t.co/DQLXMsOuro @nresearchnews #UMassMedNews
Open

Guangping Gao makes list of Nature Biotechnology Top 20 translational researchers

Guangping Gao makes list of Nature Biotechnology Top 20 translational researchers

An influential scientific journal’s list of top translational biotech researchers for 2019 includes Guangping Gao, PhD. Rankings are based on total patents for the year, among other ...

On Oct 15, 2020
@pharminews shared
Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing https://t.co/5cgcAngtEG #news #pharma #pharmiweb
Open

Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing

Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing

Syndicate led by leading life science investors Northpond Ventures alongside Octopus VenturesOctober 14, 2020, London, UK and Woodcliff Lake, NJ - Ori Biotech Ltd (Ori), a leading innovator ...

On Oct 16, 2020
@BioWorld shared
Australia’s device and biotech companies hold the key for future pandemic preparedness: MTPConnect report https://t.co/4fZ24cmvoK
Open

Australia’s device and biotech companies hold the key for future pandemic preparedness: MTPConnect report

Australia’s device and biotech companies hold the key for future pandemic preparedness: MTPConnect report

PERTH, Australia – During the COVID-19 pandemic, 90% of Australia’s clinical trials were put on hold, and the market cap of biotech and medical device companies on the Australian Securities ...

On Oct 16, 2020
@biospace shared
Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry #biospace #lifesciences #biotechnology #pharmaceuticals #3D #Bioprinting https://t.co/LHXSLKg1BA
Open

Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry

Manufacturing a Personalized Cellular Universe: 3D Bioprinting in the Biotech Industry

By using naturally-derived scaffolds, human cells and other biocompatible materials, 3D bioprinting has ushered in opportunities for researchers to design, print and optimize patient ...

On Oct 13, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: October 13 #biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/AuDpHnjb3t
Open

Biopharma Update on the Novel Coronavirus: October 13

Biopharma Update on the Novel Coronavirus: October 13

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020.

Browse topics

Get updates live! Follow us on

Choose your newsletters

On Oct 15, 2020
@SynBioBeta shared
The Chief of Staff Role in the #Biotech Industry: Despite being a nebulous and somewhat new role in the startup world, the Chief of Staff role is starting to become more accepted in the industry. https://t.co/1wz1TPjhXf @BioeconomyXYZ #synbio
Open

The Chief of Staff Role in the Biotech Industry

The Chief of Staff Role in the Biotech Industry

Despite being a nebulous and somewhat new role in the startup world, the Chief of Staff role is starting to become more accepted.

On Oct 14, 2020
@SynBioBeta shared
Repositioning microbial biotechnology against COVID‐19: the case of microbial production of flavonoids https://t.co/OlbtpePrTU #synbio
Open

Repositioning microbial biotechnology against COVID‐19: the case of microbial production of flavonoids

Repositioning microbial biotechnology against COVID‐19: the case of microbial production of flavonoids

Coronavirus‐related disease 2019 (COVID‐19) became a pandemic in February 2020 and worldwide researchers try to tackle the disease with approved drugs of all kinds, or to develop novel ...

On Oct 15, 2020
@pharminews shared
B.R.A.I.N. Biotechnology Research And Information Network AG: Two experts join the BRAIN AG Supervisory Board https://t.co/RPS7KTq4xv #news #pharma #pharmiweb
Open

B.R.A.I.N. Biotechnology Research And Information Network AG: Two experts join the BRAIN AG Supervisory Board

B.R.A.I.N. Biotechnology Research And Information Network AG: Two experts join the BRAIN AG Supervisory Board

DGAP-News: B.R.A.I.N. Biotechnology Research And Information Network AG / Key word(s): Personnel15.10.2020 / 16:07 The issuer is solely responsible for the content of this ...

On Oct 15, 2020
@JohnCendpts shared
The Sanofi/Translate team hits the green light on an early-stage study for their mRNA Covid-19 vaccine after seeing it work in animals https://t.co/rE5BCHsvQ8
Open

The Sanofi/Translate team hits the green light on an early-stage study for their mRNA Covid-19 vaccine after seeing it work in animals

The Sanofi/Translate team hits the green light on an early-stage study for their mRNA Covid-19 vaccine after seeing it work in animals

Sanofi and their mRNA vaccine partners at Translate Bio say they got the preclinical animal data on the Covid-19 antibodies they were looking for, beating out convalescent serum. And that ...

On Oct 15, 2020
@JohnCendpts shared
Novartis vet Danny Bar-Zohar leaps back into R&D, taking over the team at Merck KGaA as Luciano Rossetti steps out https://t.co/mIZKWSp0hN
Open

Novartis vet Danny Bar-Zohar leaps back into R&D, taking over the team at Merck KGaA as Luciano Rossetti steps out

Novartis vet Danny Bar-Zohar leaps back into R&D, taking over the team at Merck KGaA as Luciano Rossetti steps out

After a brief stint as a biotech investor at Syncona, Novartis vet Danny Bar-Zohar is back in R&D, and he’s taking the lead position at Merck KGaA’s drug division. Bar-Zohar had led ...

On Oct 19, 2020
@JohnCendpts shared
RT @endpts: CAR-plus: Irish biotech recruits Kite alum Chris Nowers to prep dual-targeting NK cell therapy for the clinic https://t.co/fcew2445zb
Open

CAR-plus: Irish biotech recruits Kite alum Chris Nowers to prep dual-targeting NK cell therapy for the clinic

CAR-plus: Irish biotech recruits Kite alum Chris Nowers to prep dual-targeting NK cell therapy for the clinic

Soon after Chris Nowers left Cell Medica — freshly rebranded Kuur Therapeutics — in February, the Kite Pharma alum was introduced to another cell therapy player. The basic idea of building ...

On Oct 15, 2020
@SynBioBeta shared
The first step in building ethical technology is for companies to understand their weaknesses and red team their thinking. “Under what conditions would the very thing that I’m saying would be great for the world lead to the exact opposite of that?” https://t.co/cuEqgq2BoN
Open

The Social Dilemma: What Can The Biotech Industry Learn From The Failures Of The Social Media Industry?

The Social Dilemma: What Can The Biotech Industry Learn From The Failures Of The Social Media Industry?

The synthetic biology community is working hard to avoid a social media-like catastrophe in the biotech industry.

On Oct 14, 2020
@MassBio shared
#COVID19 has accelerated the development of next-generation #diagnostics, #therapies, + #vaccines. Join our forum on 10/21 for an update on how #MA is contributing to this revolution in the #LifeSciences. Register https://t.co/bOqt3hLT7Y
Open

All Hands On Deck: The Fight Against COVID-19 In Massachusetts

All Hands On Deck: The Fight Against COVID-19 In Massachusetts

The Massachusetts Biotech Caucus along with the Massachusetts Biotechnology Council (MassBio) invite you to a special presentation All Hands On Deck: The Fight Against COVID-19 In ...

On Oct 13, 2020
@Bio_Careers shared
Building your pharmaceutical industry career as a PhD, PharmD, or MD. https://t.co/J2qu2g7R71
Open

Building your pharmaceutical industry career as a PhD, PharmD, or MD.

Building your pharmaceutical industry career as a PhD, PharmD, or MD.

Over the past 10 to 15 years, we have seen a tremendous shift in the number of pharmacists turning to the pharmaceutical industry sector (pharma) to explore new career paths. One path, in ...

On Oct 14, 2020
@pharminews shared
Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer https://t.co/6QvZp24rLv #news #pharma #pharmiweb
Open

Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer

Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer

Oxurion NV appoints Tom Graney, CFA as Chief Financial OfficerBoston-based former Vertex and Generation Bio CFO Brings Significant Operational, US Capital Markets and Investor Relations ...

On Oct 13, 2020
@NYTHealth shared
RT @katie_thomas: The world is waiting for a vaccine to get us out of this pandemic. Enter the drug industry, which is eager to rehabilitate a reputation that's been battered by high prices and the opioid crisis. with @JesseDrucker and @gelles https://t.co/rQQNrfawkn
Open

Covid-19 Vaccines Are Chance at Salvation, Financial and Beyond, for Drug Makers

Covid-19 Vaccines Are Chance at Salvation, Financial and Beyond, for Drug Makers

Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.